Table.
Participant Demographics
| Subject Code | Sex | Age, Y | Time Since Stroke, Mo | Affected Visual Hemifield | Training Group |
|---|---|---|---|---|---|
| CB1 | M | 49 | 32 | R | Intact |
| CB2 | F | 46 | 13 | R | Intact |
| CB3 | M | 72 | 20 | L | Intact |
| CB4 | M | 63 | 61 | L | Intact |
| CB5 | M | 63 | 43 | L | Intact |
| CB6 | M | 58 | 105 | R | Intact |
| CB7 | F | 74 | 338 | L | Intact |
| CB8 | M | 71 | 10 | L | Intact |
| CB9 | M | 68 | 6 | R | Intact |
| CB10 | M | 70 | 4 | L | Intact |
| CB11 | M | 70 | 58 | L | Intact |
| CB12 | F | 69 | 16 | R | Intact |
| CB13 | F | 54 | 24 | L | Intact |
| CB14 | M | 64 | 130 | L | Intact |
| CB15 | M | 56 | 13 | L | Intact |
| CB16 | M | 49 | 63 | L | Intact |
| CB17 | M | 64 | 8 | L | Intact |
| CB18 | F | 46 | 15 | R | Intact |
| CB19 | M | 64 | 20 | R | Intact |
| CB20 | M | 45 | 5 | R | Intact |
| CB21 | M | 68 | 3 | R | Intact |
| CB22 | M | 59 | 4 | R | Intact |
| CB23 | M | 71 | 6 | L | Intact |
| CB24 | M | 69 | 60 | L | Blind |
| CB25 | F | 50 | 38 | R | Blind |
| CB26 | F | 51 | 18 | L | Blind |
| CB27 | M | 42 | 15 | R | Blind |
| CB28 | M | 50 | 373 | R | Blind |
| CB29 | M | 62 | 5 | R | Blind |
| CB30 | M | 71 | 47 | R | Blind |
| CB31 | M | 56 | 8 | L | Blind |
| CB32 | M | 64 | 47 | L | Blind |
| CB33 | M | 41 | 11 | R | Blind |
| CB34 | M | 57 | 4 | L | Blind |
| CB35 | F | 44 | 10 | R | Blind |
| CB36 | M | 66 | 105 | L | Blind |
| CB37 | M | 66 | 36 | R | Blind |
| CB38 | M | 32 | 5 | R | Blind |
| CB39 | F | 47 | 5 | L | Blind |
| CB40 | F | 63 | 3 | L | Blind |
| CB41 | M | 49 | 14 | R | Blind |
| CB42 | M | 69 | 3 | L | Blind |
| CB43 | M | 72 | 6 | L | Blind |
F, female; L, left; M, male; R, right.